Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Warrants

<< Previous

Bullboard Posts

Next >>

Comment by lonc17on Feb 17, 2021 6:26pm

116 Views

Post# 32591383

RE:RE:RE:RE:RE:RE:Warrants

Yeg,

I give up. This will be my last post on this topic.

If the statement you cut and paste was still true then the warrants would be trading a hell of a lot higher.

The warrants were affected by the reverse split.
YOU NEED 9.5 WARRANTS and about $9 to receive one share of ONC.TO

"Each common share purchase warrant entitles the holder to purchase one common share at an exercise price of US$0.90 until August 16, 2024.

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments